Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients.
St Michael's Hospital, Toronto, Ontario, Canada.
J
J
Zaltzman
V
V
McAlister
D
D
Russell
P
P
Halloran
D
D
Landsberg
S
S
Busque
A
A
Shoker
A
A
Boucher
J
J
Shapiro
J
J
Tchervenkov
J
J
Peets
D000208:Acute Disease; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D016559:Tacrolimus